Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05463133
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2022-07-15
Brief Title:
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease CGD With an Alemtuzumab Busulfan and TBI-based Conditioning Regimen Combined With Cytokine IL-6 - IFN-gamma Antagonists
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC